Manipur: Imphal West chosen as pilot district for digital health transformation drive

Guwahati, June 25 -- Reported by Bit Irom Imphal: The National Health Authority (NHA), in collaboration with the Government of Manipur, has launched an ambitious initiative to modernise the state's h... Read More

Govt tells public sector banks to expand deeper into Rural India

New Delhi, June 25 -- The Union finance ministry has asked public sector banks (PSBs) to accelerate their rural expansion and ensure access in villages with a population of more than 3,000, according ... Read More

Riot Vanguard may finally stop haunting your taskbar

India, June 25 -- Riot Games is giving some PC players a little more breathing room. Vanguard, the company's anti-cheat system for games such as League of Legends and VALORANT, will soon support an op... Read More

Preventive Health Platform SuperLiving Bags $7 Mn To Scale In Tier II & III Cities

India, June 25 -- AI-native health and nutrition-focused platform SuperLiving has raised $7 Mn (about Rs.65.9 Cr) in its Series A funding round led by Lightspeed, with participation from existing inve... Read More

Uranium below detectable limits in crop samples: Punjab to NGT

Chandigarh, June 25 -- Uranium was detected in several irrigation water and soil samples collected during a statewide study, but the findings cannot be judged against the World Health Organization's (... Read More

Indore bizman, woman found dead in car; gun, axe, note recovered: MP police

Bhopal, June 25 -- A 26-year-old businessman from Indore and his 24-year-old partner were found dead inside a car in Madhya Pradesh's Ashok Nagar district on Thursday morning, with police recovering a... Read More

Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, June 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More

Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, June 25 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More

Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 25 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 25 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More

• ««
• «
• 8984
• 8985
• 8986
• 8987
• 8988
• 8989
• 8990
• 8991
• 8992
• 8993
• »
• »»